Omega Healthcare Investors (OHI) Earnings: Q3 2026 Results and Next Report Date

The quarter ended September 30, 2026 and Omega Healthcare Investors published the results on November 3, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. Omega Healthcare Investors reports EPS two ways: GAAP, under the accounting rules every US filer follows, and Adjusted FFO per diluted share, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Revenue here is Omega's GAAP total revenues, the REIT's own top line. Adjusted FFO (AFFO) is Omega's main per-share earnings measure, so it is shown in place of adjusted EPS.
• Resident fees and services come from senior housing run under RIDEA structures, which Omega began using in the fourth quarter of 2025, so there is no year-ago figure. Omega also reclassified prior-period expenses into a new property-level expenses line.

Source: Omega Healthcare Investors Q3 2026 results, November 3, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How Omega Healthcare Investors splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• Omega Healthcare Investors's Rental income revenue was $253 million in Q3 2026, down 3% from $261 million in Q3 2025, 74% of total revenue.
• Omega Healthcare Investors's Real estate tax and ground lease income revenue was $4.2 million in Q3 2026, up 10% from $3.8 million in Q3 2025, 1% of total revenue.
• Omega Healthcare Investors's Real estate loans interest income revenue was $34.2 million in Q3 2026, down 1% from $34.4 million in Q3 2025, 10% of total revenue.
• Omega Healthcare Investors's Non-real estate loans interest income revenue was $7.7 million in Q3 2026, down 26% from $10.4 million in Q3 2025, 2% of total revenue.
• Omega Healthcare Investors's Resident fees and services revenue was $30.8 million in Q3 2026, 9% of total revenue.
• Omega Healthcare Investors's Miscellaneous income revenue was $11.0 million in Q3 2026, up 389% from $2.2 million in Q3 2025, 3% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

Omega guides on Adjusted FFO per share only, with no revenue or GAAP EPS outlook. The second and third quotes are among the assumptions listed under that guidance.

In its Q3 2026 release, Omega Healthcare Investors said:

“The Company's expected 2026 Adjusted FFO range is $3.28 to $3.30 per diluted share compared to the previous range of $3.22 to $3.26 per diluted share.”

“quarterly G&A expense of approximately $14 million to $15.5 million”

“Maplewood continues to pay monthly rent of $6.9 million, consistent with September 2026”

Source: Omega Q3 2026 release, Nov 3, 2026.

This is the company's own guidance as of Nov 3, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the OHI forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP total revenues and diluted EPS (net income available to common stockholders), each as first reported in that quarter's release. Q2 2026 EPS of $1.19 includes gains on assets sold.

Omega Healthcare Investors's next report is expected around February 3, 2027, a date estimated from its reporting history that the company has not yet confirmed. This page will show Q3 2026 until those results are out and have been checked against the release.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 3, 2026

Omega Healthcare Investors is a REIT that owns and lends against long-term care properties, mainly skilled nursing facilities (SNFs) and assisted living facilities, including U.K. care homes. Most of its income is rent from triple-net leases: rental income was $252.8 million of Q3 2026 total revenues of $340.6 million, down from $260.7 million a year earlier. Real estate loans interest income added $34.2 million and non-real estate loans interest income $7.7 million. (Omega Q3 2026 release, Nov 3, 2026; Omega Form 10-Q, Q3 2026, Nov 4, 2026)

The growth line is new. Omega began running some senior housing under RIDEA structures in the fourth quarter of 2025, which brings the communities' resident fees and services into its revenue ($30.8 million in Q3 2026, none a year earlier) along with their costs, which pushed property-level expenses to $29.9 million from $4.0 million. In Q3 2026 Omega paid £35.8 million ($48.0 million) to convert 30 U.K. care homes from triple-net leases to RIDEA structures. (Omega Q3 2026 release, Nov 3, 2026; Omega Form 10-Q, Q3 2026, Nov 4, 2026)

At September 30, 2026 the portfolio comprised 1,036 operating healthcare facilities in 41 states, Washington, D.C., the U.K. and Jersey, run by 93 third-party operators or managers. The largest geographic concentrations were the U.K. at 17.6% of real estate assets and mortgages, Texas at 9.2% and Indiana at 6.3%. No operator exceeded 10% of total revenues; CommuniCare, above that line a year ago, generated 5.0% in Q3 2026 against 9.9% in Q3 2025. (Omega Form 10-Q, Q3 2026, Nov 4, 2026)

Operator changes moved the numbers. Omega recognized $13.3 million of rental income and $4.8 million of interest income from Genesis, whose bankruptcy sale closed in October 2026 with Omega's lease assigned to the buyer and $149.5 million of loans repaid. On October 1, 2026 it moved 32 Florida SNFs to PACS at initial annual rent of $58.0 million, up $26.1 million, paying a $90.0 million termination fee to the prior operator. At September 30, 22 operators were on a cash basis of revenue recognition, representing 21.6% of total revenues for the first nine months. (Omega Q3 2026 release, Nov 3, 2026; Omega Form 10-Q, Q3 2026, Nov 4, 2026)

Omega Healthcare Investors' GAAP diluted EPS fell to $0.27 in Q3 2026 from $0.59, while Adjusted FFO rose to $0.82 per diluted share from $0.79. GAAP net income carried $82.0 million of depreciation and amortization, $59.9 million of acquisition, merger and transition related costs (mostly the payments to end the U.K. leases), $18.8 million of severance expense and an $11.4 million impairment. AFFO adds all of these back. (Omega Q3 2026 release, Nov 3, 2026)

The year-ago quarter's GAAP figure was lifted by a $28.3 million gain on assets sold, against a $0.4 million loss in Q3 2026. Nareit FFO, which keeps the transition costs and severance in, was $0.60 per share against $0.78, and Funds Available for Distribution was $0.78 against $0.75. (Omega Q3 2026 release, Nov 3, 2026)

Omega's per-share figures use diluted shares including Omega OP Units: 321.0 million in Q3 2026, against 308.2 million. It issued 4.7 million common shares in the quarter for gross proceeds of $234 million, and declared a quarterly dividend of $0.68 per share. (Omega Q3 2026 release, Nov 3, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

Omega Healthcare Investors guides on one figure, Adjusted FFO per share, and gives no revenue or GAAP EPS outlook. With Q3 results it raised its 2026 range to $3.28 to $3.30 per diluted share, from $3.22 to $3.26. (Omega Q3 2026 release, Nov 3, 2026)

The guidance assumes NewGen pays its full contractual rent of $13.3 million per quarter, Maplewood keeps paying monthly rent of $6.9 million, quarterly G&A of about $14 million to $15.5 million, $306 million of loans repaid in the fourth quarter and quarterly dividends of $0.68. It excludes further acquisitions and capital markets activity, such as the £631.7 million ($845.7 million) U.K. mortgage loan Omega funded in November 2026. (Omega Q3 2026 release, Nov 3, 2026)

A consensus figure is the average of the models published by the analysts who cover Omega Healthcare Investors, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones Omega Healthcare Investors's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning OHI is on is OHI a buy or a sell?, what analysts expect next is on the OHI forecast, and what the company does is on the Omega Healthcare Investors (OHI) stock page.

Every number on this page can be traced to a document Omega Healthcare Investors published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.